Search Results21-35 of  35

  • 2 / 2
  • Masuda Norikazu ID: 9000256631462

    Department of Surgery, Sakai Municipal Hospital (2002 from CiNii)

    Articles in CiNii:1

    • The Relationship between the Number of Metastatic Lymph Nodes and Prognosis of Patients with Dukes C Colon Cancer (2002)
  • Masuda Norikazu ID: 9000257909934

    Japan Breast Cancer Research Group (JBCRG) (2005 from CiNii)

    Articles in CiNii:1

    • Interim Analysis of a Phase II Trial of Cyclophosphamide, Epirubicin and 5-fluorouracil (CEF) Followed by Docetaxel as Preoperative Chemotherapy for Early Stage Breast Carcinoma (2005)
  • Masuda Norikazu ID: 9000258091785

    Central Committee for Quality of Mammography Screening, Subcommittee for Reading (2007 from CiNii)

    Articles in CiNii:1

    • Quality Assurance of Mammography Training Courses via Questionnaires : Eighth Report (2007)
  • Masuda Norikazu ID: 9000258092100

    Hannan Mammography Workshop Group (2011 from CiNii)

    Articles in CiNii:1

    • The Role of a Local Mammography Workshop, Considered from the Results of Reading Examinations and Associated Questionnaires (2011)
  • Masuda Norikazu ID: 9000298901144

    Articles in CiNii:1

    • Evaluating the 21-gene assay Recurrence Score® as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer. (2013)
  • Masuda Norikazu ID: 9000303999582

    Department of Surgery, Breast Oncology, NHO Osaka National Hospital (2015 from CiNii)

    Articles in CiNii:1

    • Everolomus, new target drug for mTOR in the field of breast cancer treatment (2015)
  • Masuda Norikazu ID: 9000344802925

    Articles in CiNii:1

    • Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy (2016)
  • Masuda Norikazu ID: 9000362802706

    Articles in CiNii:1

    • Randomized phase II study of nab-paclitaxel as first-line chemotherapy in patients with HER2-negative metastatic breast cancer (2017)
  • Masuda Norikazu ID: 9000370253298

    Articles in CiNii:1

    • Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer (2016)
  • Masuda Norikazu ID: 9000378123884

    Department of Breast Surgery, National Hospital Organization, Osaka National Hospital (2017 from CiNii)

    Articles in CiNii:1

    • A Case of Subcutaneous Tissue Metastasis of Gastric Cancer Difficult to Differentiate from Breast Cancer (2017)
  • Masuda Norikazu ID: 9000387919487

    Articles in CiNii:1

    • Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: A Japanese phase II study (2018)
  • Masuda Norikazu ID: 9000389444632

    Articles in CiNii:1

    • Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer (2017)
  • Masuda Norikazu ID: 9000397828459

    Articles in CiNii:1

    • A multicenter phase II trial of neoadjuvant letrozole plus low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer (JBCRG-07): therapeutic efficacy and clinical implications of circulating endothelial cells (2018)
  • Masuda Norikazu ID: 9000400187777

    Articles in CiNii:1

    • Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY) (2018)
  • Norikazu Masuda ID: 9000400187694

    Articles in CiNii:1

    • Neoadjuvant endocrine therapy with exemestane followed by response-guided combination therapy with low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study (2018)
  • 2 / 2
Page Top